Search Results 2731-2740 of 19604 for autoimmune hepatitis

1. A Study to Evaluate the Effectiveness and Safety of Pembrolizumab Combined with Bacillus Calmette-Guerin in High-Risk Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   - Has an active autoimmune disease that has required systemic ... - Has a known history of Hepatitis B or known active Hepatitis C virus infection - ...

2. VG161 in the Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma - Mayo Clinic

   Known to test positive for human immunodeficiency virus (HIV) or syphilis. 11. Active infection including hepatitis B (HBV) or hepatitis C (HCV) that currently

3. Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L Biliary Tract Cancer (BTC) - Mayo Clinic

   Participants receiving active hepatitis C virus ... hepatitis B and hepatitis C) requiring systemic therapy during the screening period. Active autoimmune ...

4. Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

   * active autoimmune disease requiring ... * known history of chronic viral infections such as hepatitis B virus (HBV) or hepatitis C virus (HCV) * ...

5. Gastrointestinal manifestations of common variable immunodeficiency - Mayo Clinic

   Noninfectious complications affect at least 50% of individuals with CVID and can include autoimmune disorders, lung diseases, gastrointestinal and hepatic ...

6. Measurements During Exercise to Improve Clinical Diagnostics in CV Stress Testing - Mayo Clinic

   Chronic liver disease. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 10/09/2024. Questions regarding updates ...

7. Thermography and Tissue Oximetry to Differentiate Acute Skin Failure from Pressure Injury - Mayo Clinic

   Liver (Model for End-Stage Liver Disease (MELD) Score > 20). 2 or more Vasoactive and inotrope medications infusions at time of enrollment: Dobutamine ...

8. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

   Patients must not have known or suspected autoimmune disease. ... Patients must not have a known history of HIV, hepatitis B, or hepatitis C infection that is ...

9. A Study of APR-246 and Pembrolizumab in Patients with Solid Tumor Malignancies - Mayo Clinic

   Known history of untreated human immunodeficiency virus (HIV)/HIV with a detectable viral load or active hepatitis B or active hepatitis C infection. Any of ...

10. A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies - Mayo Clinic

    Current hepatitis B infection (defined as positive for HBsAg and/or total anti-HBc). Participants with immunity to hepatitis B from previous natural ...